Gyeonggi-do, South Korea

Namchul Jung

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

where 'Filed Patents' based on already Granted Patents

1 patent (USPTO):

Title: Namchul Jung: Innovator in T-Cell Therapy

Introduction

Namchul Jung is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of biomedicine, particularly in the area of cancer treatment. His innovative approach to T-cell therapy has the potential to enhance the efficacy of cancer treatments.

Latest Patents

Namchul Jung holds a patent for a T-cell therapy method. This invention focuses on improving T-cell therapy by enhancing the cancer treatment efficacy of therapeutic T cells, such as CAR-T or TCR-T cells. The method involves stimulation with living cells that express cancer-related antigens, which can lead to more effective cancer treatments. He has 1 patent in this area.

Career Highlights

Throughout his career, Namchul Jung has worked with notable companies in the biopharmaceutical sector. He has been associated with Immunotech Biopharm Co., Ltd. and Pharos Vaccine Inc., where he has contributed to advancements in cancer therapies.

Collaborations

Namchul Jung has collaborated with talented individuals in his field, including Yu Wang and Hyunsoo Lee. These partnerships have fostered innovation and development in T-cell therapy.

Conclusion

Namchul Jung's work in T-cell therapy represents a significant advancement in cancer treatment methodologies. His innovative approach and collaborations highlight the importance of teamwork in the pursuit of medical breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…